After a hot healthcare venture capital market over the last couple of years, healthcare companies’ funding has dissipated.
“We are seeing a continued reversion to what I like to say is the historical norm level of funding. In 2020, 2021, and even the first half of 2022, there were super hot markets,” Bradley Bennett, senior director of venture partnerships and funding at Evanston, Ill.-based NorthShore University HealthSystem, told Becker’s. “We are seeing that dramatically right size.”
The demand for virtual care during the COVID-19 pandemic saw a dramatic increase in venture-backed digital health companies. Read more.
